ClearOne shareholders back issuance of 12,500,000 shares for Cortigent merger by written consent

• ClearOne board actions, backed by majority written consent, cleared key steps for a Cortigent acquisition via a July 1, 2026 merger agreement.
• Written consent dated Aug. 3, 2026 from First Finance Ltd. covered 1,641,162 shares, or 61.3% of 2,675,412 outstanding shares.
• Authorized issuance of 12,500,000 common shares to Vivani as merger consideration, a transaction expected to shift control under Nasdaq rules.
• Adopted a 2026 Omnibus Incentive Plan with a 2,500,000-share reserve for equity awards.
• Transaction terms also contemplate up to 855,000 advisor shares, a $10 million–$15 million unit financing, a reconstituted five-member board, rebranding to Cortigent Holdings.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ClearOne Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001753926-26-001395), on August 11, 2026, and is solely responsible for the information contained therein.